Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Children's National Hospital, Washington D.C., District of Columbia Boston Children's Hospital, Boston, Massachusetts Children's Mercy Kansas City, Kansas City, Missouri Primary Children's Hospital, Salt Lake City, Utah